NCT00694759View on ClinicalTrials.gov

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

pioglitazone

30 mg for 2 weeks, then 45 mg daily

DRUG

metformin

500mg twice daily for 1 week, then 1000 mg twice daily

DRUG

placebo

capsule twice daily

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT00694759 - Cortisol Regulation in Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter